Solid Biosciences (SLDB) Enterprise Value (2017 - 2026)
Solid Biosciences (SLDB) reported Enterprise Value of -$297.7 million for Q1 2026, down 41.36% on a YoY basis from -$507.7 million in Q1 2025, and down 58.5% sequentially from -$187.8 million in Q4 2025.
Solid Biosciences (SLDB) Enterprise Value (2017 - 2026) Analysis & Trends
Solid Biosciences (SLDB) has 10 years of Enterprise Value data on file, last reported at -$297.7 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 41.36% year-over-year to -$297.7 million; the trailing twelve-month figure through Mar 2026 stood at -$297.7 million (down 41.36% YoY), and the FY2025 full-year result was -$187.8 million, down 134.12% from the prior year.
- Enterprise Value eased to -$297.7 million in Q1 2026, from -$187.8 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$49.0 million in Q3 2022 to a low of -$297.7 million in Q1 2026.
- A 5-year average of -$174.0 million and a median of -$185.5 million in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value jumped 72.82% in 2022 and sank 193.67% in 2023, its largest moves.
- Tracing SLDB's Enterprise Value over 5 years: stood at -$213.7 million in 2022, then surged by 42.15% to -$123.6 million in 2023, then surged by 35.11% to -$80.2 million in 2024, then slumped by 134.12% to -$187.8 million in 2025, then tumbled by 58.5% to -$297.7 million in 2026.
- Business Quant data shows SLDB's Enterprise Value at -$297.7 million in Q1 2026, -$187.8 million in Q4 2025, and -$236.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - | -297.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -297.74 Mn |
| Dec 31, 2025 | -187.85 Mn |
| Sep 30, 2025 | -236.14 Mn |
| Jun 30, 2025 | -268.11 Mn |
| Mar 31, 2025 | -210.63 Mn |
| Dec 31, 2024 | -80.24 Mn |
| Sep 30, 2024 | -171.12 Mn |
| Jun 30, 2024 | -190.27 Mn |
| Mar 31, 2024 | -206.07 Mn |
| Dec 31, 2023 | -123.64 Mn |
| Sep 30, 2023 | -142.88 Mn |
| Jun 30, 2023 | -160.19 Mn |
| Mar 31, 2023 | -185.51 Mn |
| Dec 31, 2022 | -213.72 Mn |
| Sep 30, 2022 | -49.03 Mn |
| Jun 30, 2022 | -54.55 Mn |
| Mar 31, 2022 | -180.05 Mn |
| Dec 31, 2021 | -207.78 Mn |
| Sep 30, 2021 | -109.77 Mn |
| Jun 30, 2021 | -200.70 Mn |